Viewing Study NCT05378295


Ignite Creation Date: 2025-12-24 @ 1:55 PM
Ignite Modification Date: 2025-12-27 @ 10:13 PM
Study NCT ID: NCT05378295
Status: COMPLETED
Last Update Posted: 2024-04-23
First Post: 2022-05-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Personalized Fiber and Insulin Sensitivity
Sponsor: Maastricht University Medical Center
Organization:

Study Overview

Official Title: Personalized Microbial Substrates to Prevent Type 2 Diabetes
Status: COMPLETED
Status Verified Date: 2022-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: In this project the investigators intend to study the therapeutic potential of a personalized fibre mixture in individuals at high risk of developing T2DM, and aim to address the following key objectives:

1. To investigate whether a mixture of fermentable fibres, which differ in DP and side chains, will stimulate a broad range of SCFA-producing bacterial genera, resulting in enhanced chronic SCFA production throughout the whole colon with a large variation between individuals;
2. To unravel whether providing personalized fibre mixtures, selected based on the individuals' initial microbiota and capacity for SCFA production is crucial to successfully improve host insulin sensitivity and metabolic health
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: